Success Story: Thanks To Our Expert Strategy, NIW Approval Secured for a Biomedical Sciences Researcher From Iran
Client’s Testimonial:
“Thank you so much for everything you have done for me. I truly appreciate all of your hard work, dedication, and support throughout this process. Especially under such difficult circumstances, your team managed to achieve the best possible outcome for my case, and I am incredibly grateful. Congratulations to your amazing team as well! This approval is a great achievement, and I sincerely want to congratulate everyone who worked on my case. Everything from the very beginning was handled even better than I had expected. Thank you again for your professionalism, guidance, and patience throughout this journey.”
On September 7th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: Iran
State of Residence at the Time of Filing: Ontario
Approval Notice Date: September 7th, 2026
Processing Time: 7 months, 18 days (Premium Processing Updated Requested)
Case Summary:
We are pleased to share the I-140 National Interest Waiver (NIW) approval of a biomedical sciences researcher. Holding a Ph.D. in health sciences, the client currently conducts research evaluating natural plant compounds, molecular microbiology mechanisms, and cardiovascular and renal function.
The client’s research addresses critical healthcare challenges related to the expanding national burden of hypertension, diabetes, and cardiovascular disease. These contributions align directly with U.S. healthcare priorities, including national initiatives to reduce chronic disease prevalence, improve metabolic health, and alleviate the immense financial burden on the national healthcare system.
At the time of filing, the client had authored 4 peer-reviewed journal articles (3 first-authored) in leading international scientific venues. His published body of work had accumulated 394 citations from independent researchers worldwide. Bibliometric percentile data showed that two of his publications ranked among the top 10% and top 20% most-cited articles in his field for their respective publication years. Rather than presenting metrics as self-evidently sufficient, we analyzed how adjudicators view high citation volume, premier publication placement, and top percentile rankings as objective evidence of sustained field-wide influence.
Field experts highlighted the client’s specialized ability to integrate phytochemical analysis, molecular biology, and experimental modeling. Expert testimonials further corroborated the practical necessity and clinical value of his ongoing research in natural product development.
USCIS approved the client’s I-140 NIW petition, recognizing the national importance of his work in biomedical sciences, particularly his efforts to advance safe, plant-based therapeutics for hypertension and metabolic disorders. This outcome supports his continued contributions to healthcare innovation and chronic disease management in the United States. We congratulate him on this approval and wish him continued success.